Results 201 to 210 of about 143,950 (267)

Chemotherapy and the Skin: Understanding Dermatologic Side Effects. [PDF]

open access: yesCureus
Unnikrishnan P   +5 more
europepmc   +1 more source

Mitochondrial Carrier SLC25A13 Drives Ferroptosis Resistance and Immune Evasion via a STAT3–IFI6 Circuit in Breast Cancer

open access: yesAdvanced Science, EarlyView.
SLC25A13 is identified as an immunometabolic driver of triple‐negative breast cancer that sustains ferroptosis resistance and immune evasion through a STAT3–IFI6 circuit. Pharmacologic degradation of SLC25A13 restores ferroptosis sensitivity and enhances anti‐PD‐1 efficacy, highlighting a strategy to convert immune‐cold tumors into immunotherapy ...
Yingze Zhu   +8 more
wiley   +1 more source

How Advanced Artificial Intelligence Technologies Shape Drug–Drug and Drug–Target Interaction Modeling

open access: yesAdvanced Science, EarlyView.
This review explores the convergence of artificial intelligence technologies in modeling drug–drug and drug–target interactions. By evaluating advanced feature engineering, architectural innovations, and learning paradigms reveals shared evolutionary trends and critical challenges, such as cold‐start settings and shortcut learning.
Xin Sun, Tong Wang
wiley   +1 more source

A Folded, Structure‐Integrated Bimodal Sensor Enabling Non‐Contact and Tactile Perception for Intelligent Robots

open access: yesAdvanced Science, EarlyView.
A foldable bimodal sensor integrates a triboelectric nanogenerator and graphene piezoresistive effect into a monolithic laser‐induced graphene film. It enables synchronous non‐contact and tactile perception, achieving a distance of 110 mm, a sensitivity of 11.2 kPa−1, and a response time of 10 ms.
Weixiong Yang   +10 more
wiley   +1 more source

Hypotonia and Lethargy as Potential Adverse Effect to Nirsevimab Administration in a Newborn Infant. [PDF]

open access: yesJ Pediatr Pharmacol Ther
Molina VMV   +4 more
europepmc   +1 more source

SuFEx‐Enabled Reprogramming of Flavonoids for Selective α‐Glucosidase Covalent Inhibition

open access: yesAdvanced Science, EarlyView.
Selective inhibition of intestinal α‐glucosidase remains limited by poor enzyme specificity and off‐target metabolic effects. Here, SuFEx click chemistry is used to reprogram natural flavonoids into covalent inhibitors with enhanced α‐glucosidase selectivity and controlled reactivity. This strategy enables effective regulation of carbohydrate digestion
Fengyu Guo   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy